The pipeline

The WTC adjuvant pipeline has been successfully tested in different R&D models such as OVA, as well as for various indications.

 WTC adjuvants have been tested in various species, through an internal R&D program or private and public collaboration.

Results so far have confirmed NKT activity in vivo in mice and non human primates. In vitro/ex vivo  in human neonates, adults and elderly also confirm such effect.

In addition, the effects of the adjuvant in mice and primates have been well demonstrated in several models.